Lungs News and Research

RSS

ArQule reports net loss of $1,466,000 for first quarter 2011

ArQule, Inc. today announced its financial results for the first quarter of 2011.

5 May 2011

New test can diagnose deadly human fungal infections

Deadly human fungal infections caused by certain strains of Aspergillus fungi appear to be developing resistance to current drug treatments at an alarming rate, say scientists.

5 May 2011

Study explores impact of environmental toxins on health care costs and childhood morbidity

In three new studies published in the May issue of the journal Health Affairs, Mount Sinai School of Medicine researchers reveal the staggering economic impact of toxic chemicals and air pollutants in the environment, and propose new legislation to mandate testing of new chemicals and also those already on the market.

5 May 2011

Nation's emergency physicians warn about dangers linked with deep vein thrombosis

As temperatures warm and travel picks up around the country, the nation's emergency physicians issue a warning about the serious dangers associated with deep vein thrombosis.

5 May 2011

New CDC data on World Asthma Day highlights importance of air quality standards

The simple act of taking a breath is a challenge for three million Hispanics with asthma," said Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic Health, the nation's leading Hispanic health advocacy group.

4 May 2011

New nano-vault delivery system can fight cancer

UCLA scientists have discovered a way to wake up the immune system to fight cancer by delivering an immune system-stimulating protein in a nanoscale container called a vault directly into lung cancer tumors, harnessing the body's natural defenses to fight disease growth.

4 May 2011

Exercise linked to improved lung status in children with cystic fibrosis

A small Johns Hopkins Children's Center study of children and teens with cystic fibrosis shows that simple exercise, individually tailored to each patient's preference and lifestyle, can help improve lung function and overall fitness.

4 May 2011

NanoViricides' FluCide drug candidate greatly reduces lung viral load in animals

NanoViricides, Inc. reports that post-infection treatment with its optimized FluCide drug candidates achieved 1,000-fold reduction in the levels of infectious virus in the lungs of animals with a lethal level of influenza virus infection.

3 May 2011

National survey reveals severe asthmatics need more treatment options

Today on World Asthma Day 2011, despite decades of progress on the management and control of asthma – more research, better understanding and powerful treatments – millions of people with severe asthma are still living with serious, frequent, life-threatening symptoms.

3 May 2011

Belly fat predicts heart-disease risk better than BMI: Study

According to the latest study the fat around the belly is the chief culprit in the link between obesity and cardiovascular disease. This study raises the possibility that people can be overweight without significantly raising their heart risk, so long as they carry the extra fat in places other than their belly. In fact, a few extra pounds may even lower the risk of death from heart disease, researchers found.

3 May 2011

Statins can help reduce lung damage in severe abdominal sepsis

Statins may be best known for their ability to reduce cholesterol, but a research report appearing in the May 2011 issue of the Journal of Leukocyte Biology shows that these same drugs could also play a crucial role in the reduction of lung damage resulting from severe abdominal sepsis and infection.

3 May 2011

Temsirolimus with chemotherapy may serve as promising therapy for mesothelioma

A drug commonly used to treat kidney cancer may increase the effectiveness of chemotherapy for mesothelioma, according to a study published in the May issue of the Journal of Thoracic Oncology.

2 May 2011

Sorin first quarter consolidated revenues increase 4.7% to €182.3 million

For the second quarter of 2011, Sorin Group expects revenues to grow 1 - 2% compared to the same period of 2010 and a net profit of approximately €14 - 16 million.

30 Apr 2011

NewYork-Presbyterian Hospital/Weill Cornell Medical Center to present research studies at 2011 ATC

Available for expert commentary on the latest research findings presented at the 2011 American Transplant Congress in Philadelphia, April 30 to May 4, is Dr. Sandip Kapur, chief of transplant surgery and director of kidney and pancreas transplant programs at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and a leading authority on transplantation.

30 Apr 2011

Ontario Lung Association to launch new asthma education book to mark World Asthma Day

In Ontario, an astounding 1.7 million people have asthma, making it one of the most widespread chronic diseases. Nearly half of them don't have it under control and yet asthma is a disease that must be well managed because there is no cure.

30 Apr 2011

FDA announces steps to help reduce risk of exposure to improperly reprocessed devices

The U.S. Food and Drug Administration today announced steps to help reduce the risk of exposure to improperly reprocessed devices that can lead to the transmission of disease.

30 Apr 2011

UCSF nursing professor earns AACN-GE recognition for cardiac care

RN, PhD, FAAN, Lillian & Dudley Aldous Professor of Nursing Science, School of Nursing, University of California San Francisco — will receive the AACN-GE Healthcare Pioneering Spirit Award.

30 Apr 2011

Pearl's PT003 Phase 2b study results in COPD to be presented at ATS meeting

Pearl Therapeutics Inc. announced today that complete results from the Company's Phase 2b study of PT003 in patients with moderate-to-very severe COPD will be presented during a late-breaker poster session at the upcoming annual meeting of the American Thoracic Society.

30 Apr 2011

Video games can serve as respiratory therapy for children with cystic fibrosis

Video games controlled by the player's breath can encourage youths with cystic fibrosis to use techniques that can help keep their airways clearer, according to a study to be presented Saturday, April 30, at the Pediatric Academic Societies annual meeting in Denver.

30 Apr 2011

Bristol-Myers Squibb first quarter net sales increase 5% to $3.3 billion

Bristol-Myers Squibb Company today announced first quarter results that included strong sales and earnings growth, and several key R&D milestones—most notably U.S. regulatory approval for YERVOY. The company also confirmed guidance for the year.

30 Apr 2011